WCN26-4179 STABILIZED MAFB ACTIVATES IGF-1/PI3K/AKT TO CAUSE FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN MULTICENTRIC CARPOTARSAL OSTEOLOSIS: GENETIC AND PHARMACOLOGIC RESCUE

Read full text Summarise with VIRAT
Authors: Shun Ishibashi, Toshiaki Usui, Naoki Morito, Michito Hamada, Mayuko OKI, Eugenia Kumaga, Yuka Murakami, Natalia Gogoleva, Shunya Sadaki, Akihiro Kuno, Takashi Kudo, Seiya Mizuno
+3 more Masafumi Muratani, Ryojiro Tanaka, Satoru Takahashi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Multicentric carpotarsal osteolysis (MCTO) is an ultra-rare osteolysis syndrome frequently complicated by progressive nephropathy. Dominant missense variants clustered in the MAFB transactivation domain are causative, yet renal pathogenesis and targeted therapies remain undefined. MAFB is a bZIP transcription factor that binds Maf recognition elements (MAREs); in podocytes, it maintains homeostasis and directly regulates the slit-diaphragm proteins NPHS1 (nephrin) and NPHS2 (podocin). We investigated how MCTO-associated MAFB (MCTO-MAFB) perturbs podocytes and whether inhibition of the IGF-1/PI3K/AKT axis mitigates injury.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Dermatological and Skeletal Disorders

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105114–105114
Publication date
25 March 2026
Language
EN